Appendix A: Cost–utility analysis of single nucleotide polymorphism panel-based machine learning algorithm to predict risk of opioid use disorder.docx

Lars H Ehlers (Bidrager)
Niels Ejskjær (Bidrager)
Pia Holmgaard (Bidrager)
Susanne Sandgaard (Bidrager)
Mark Lamotte (Bidrager)
Evan C. Frary (Bidrager)
Mafalda C Ramos (Bidrager)

Datasæt

Beskrivelse

Appendix A – Model Assumptions and Parameter Summary

Dato for tilgængelighed	2021
Forlag	Future Science Group

DOI
10.25402/fsg.16843948.v1

Adgang til datasæt

https://future-science-group.figshare.com/articles/dataset/Appendix_A_Cost_utility_analysis_of_single_nucleotide_polymorphism_panel-based_machine_learning_algorithm_to_predict_risk_of_opioid_use_disorder_docx/16843948/1

1 Tidsskriftartikel

The cost-effectiveness of oral semaglutide versus empagliflozin in Type 2 diabetes in Denmark
Ehlers, L. H., Lamotte, M., Ramos, M. C., Sandgaard, S., Holmgaard, P., Frary, E. C. & Ejskjær, N., jan. 2022, I: Journal of Comparative Effectiveness Research. 11, 1, s. 29-37 9 s.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Åben adgang
Fil
8 Citationer (Scopus)

104 Downloads (Pure)

Citationsformater

Ehlers, L. H. (Bidrager), Ejskjaer, N. (Bidrager), Holmgaard, P. (Bidrager), Sandgaard, S. (Bidrager), Lamotte, M. (Bidrager), Frary, E. C. (Bidrager), Ramos, M. C. (Bidrager) (2021). Appendix A: Cost–utility analysis of single nucleotide polymorphism panel-based machine learning algorithm to predict risk of opioid use disorder.docx. Future Science Group. 10.25402/fsg.16843948.v1

Appendix A: Cost–utility analysis of single nucleotide polymorphism panel-based machine learning algorithm to predict risk of opioid use disorder.docx

Beskrivelse

DOI

Adgang til datasæt

Publikation

The cost-effectiveness of oral semaglutide versus empagliflozin in Type 2 diabetes in Denmark

Citationsformater